The Importance of the Physician in the Generic Versus Trade-Name Prescription Decision

Rand Journal of Economics, Vol. 29, No. 1 (Winter 1997)

Posted: 5 Mar 1998

See all articles by Judith K. Hellerstein

Judith K. Hellerstein

University of Maryland - Department of Economics; National Bureau of Economic Research (NBER)

Abstract

I examine the importance of physicians in the process by which patients receive either trade-name or generic drugs. Using a dataset on physicians, their patients, and the multisource drugs prescribed, I find that almost all physicians prescribe both types of drugs to their patients, but some physicians are more likely to prescribe generic drugs while other physicians are more likely to prescribe trade-name drugs. Very little of the prescription decision can be explained by observable characteristics of individual patients, but all of the evidence indicates that physicians are indeed an important agent in determining whether patients receive either trade-name or generic drugs.

JEL Classification: I11, L69

Suggested Citation

Hellerstein, Judith K., The Importance of the Physician in the Generic Versus Trade-Name Prescription Decision. Rand Journal of Economics, Vol. 29, No. 1 (Winter 1997). Available at SSRN: https://ssrn.com/abstract=57718

Judith K. Hellerstein (Contact Author)

University of Maryland - Department of Economics ( email )

College Park, MD 20742
United States
301-405-3545 (Phone)
301-405-3542 (Fax)

National Bureau of Economic Research (NBER)

1050 Massachusetts Avenue
Cambridge, MA 02138
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
1,474
PlumX Metrics